Australia markets closed

ResMed Inc. (RMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
183.78-0.44 (-0.24%)
At close: 04:00PM EDT
183.76 -0.02 (-0.01%)
After hours: 06:58PM EDT

ResMed Inc.

9001 Spectrum Center Boulevard
San Diego, CA 92123
United States
858-836-5000
https://www.resmed.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Michael J. Farrell BE, MBA, SMCEO & Chairman2.87M11.2M1972
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScDFounder, Chair Emeritus & Director430.21kN/A1942
Mr. Brett A. SandercockChief Financial Officer909.64k1.79M1967
Mr. Robert A. DouglasSpecial Advisor1.91M8.98M1960
Mr. Kaushik GhoshalChief Commercial Officer - SaaS1.11MN/A1969
Ms. Amy WakehamChief Investor Relations OfficerN/AN/AN/A
Mr. Michael J. RiderChief Legal OfficerN/AN/A1958
Mr. Jim EllisChief Compliance OfficerN/AN/AN/A
Ms. Yvonne-Katrin PucknatChief Marketing OfficerN/AN/AN/A
Ms. Vered KeisarChief People OfficerN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.

Corporate governance

ResMed Inc.’s ISS governance QualityScore as of 1 April 2024 is 4. The pillar scores are Audit: 1; Board: 8; Shareholder rights: 3; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.